ANEB Valuation

Anebulo Pharmaceuticals Inc (ANEB) has a current Price-to-Book (P/B) ratio of 9.39. Compared to its 3-year average P/B ratio of 9.25 , the current P/B ratio is approximately 1.51% higher. Relative to its 5-year average P/B ratio of -9.76, the current P/B ratio is about -196.25% higher. Anebulo Pharmaceuticals Inc (ANEB) has a Forward Free Cash Flow (FCF) yield of approximately -6.31%. Compared to its 3-year average FCF yield of -13.37%, the current FCF yield is approximately -52.84% lower. Relative to its 5-year average FCF yield of -10.57% , the current FCF yield is about -40.34% lower.